Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (19 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenues
183
316
287
77
87
84
71
96
Cost of revenues
131
201
308
83
72
73
67
74
Gross Profit
0
0
0
0
0
11
3
22
Research and development
20
24
33
27
15
12
12
12
Selling, general and administrative
38
50
72
72
50
37
29
29
Arbitration award expense
0
0
0
0
0
0
9
0
Restructuring and impairments
1
0
50
9
8
3
5
1
Write-off of advance payment
0
0
0
21
0
0
0
0
Amortization of acquisition related intangibles
2
2
2
1
0
0
0
0
Total operating expenses
191
277
465
213
145
53
56
42
Operating loss
-8
39
-178
-136
-58
-41
-53
-20
Change in fair value of derivatives and warrants
0
0
0
0
8
2
4
0
Loss on extinguishment of debt
0
0
0
0
0
-5
0
0
Gain on sale of minority interests
0
0
0
0
0
0
0
3
Interest expense, net
3
1
1
0
-15
-10
-2
-1
Other (expense) income, net
-2
-3
7
1
-1
-1
2
-2
Loss before income tax expense
-8
37
-170
-135
-66
-55
-49
-21
Income tax expense (benefit)
9
21
16
1
0
1
0
2
Net loss
-17
16
-186
-137
-66
-56
-49
-23
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Jun 14, 2013 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on May 31, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (41 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
88
124
46
39
43
20
39
Marketable securities
n/a
54
116
5
0
0
0
0
Accounts receivable, net
n/a
57
15
19
19
8
10
19
Inventory
n/a
36
26
29
33
21
21
19
Prepaid expenses and other current assets
n/a
20
33
31
22
9
11
6
Restricted cash
n/a
6
6
12
6
3
3
0
Deferred tax assets
n/a
2
0
0
0
0
0
0
Total current assets
n/a
263
320
144
120
83
65
83
Property, plant and equipment, net
n/a
64
96
91
75
65
56
50
Goodwill
n/a
37
0
0
0
0
0
0
Intangibles, net
n/a
8
7
4
3
2
1
1
Marketable securities
n/a
7
0
0
0
0
0
0
Restricted cash
n/a
0
0
3
5
3
1
1
Deferred tax assets
n/a
3
6
3
5
8
8
0
Other assets
n/a
18
12
11
9
8
3
0
Total assets
n/a
400
441
255
217
169
134
135
Liabilities and owners' equity
Accounts payable and accrued expenses
n/a
84 84319000
90 90273000
38 37582000
32 31578000
22 21764000
22 21615000
23 23156000
Note payable, current portion, net of discount of $42 as of March 31, 2016 and $244 as of March 31, 2015
n/a
0 0
0 0
0 0
4 4158000
6 6240000
4 3756000
3 2624000
Convertible note, current portion, net of discount of $1,287 as of December 31, 2013 and $4,289 as of March 31, 2013
n/a
0 0
0 0
0 0
5 4610000
0 0
0 0
0 0
Derivative liabilities
n/a
0 0
0 0
0 0
4 4162000
3 2601000
3 2999000
3 3227000
Adverse purchase commitments
n/a
0 0
39 38763000
26 25894000
0 0
0 0
0 0
0 0
Deferred revenue
n/a
20 19970000
10 10304000
20 19718000
30 29805000
9 9456000
11 11019000
12 12000000
Deferred tax liabilities
n/a
0 471000
6 5840000
3 3129000
5 5444000
8 7761000
8 7843000
0 0
Total current liabilities
n/a
105 104760000
145 145180000
86 86323000
80 79757000
48 47822000
47 47232000
41 41007000
Note payable, net of discount of $133 as of March 31, 2016 and $290 as of March 31, 2015
n/a
0 0
0 0
0 0
3 3367000
6 6380000
4 3877000
1 1367000
Convertible note, net of discount of $600 as of March 31, 2013
n/a
0 0
0 0
0 0
6 5881000
0 0
0 0
0 0
Deferred revenue
n/a
13 13302000
2 2181000
2 1558000
1 1340000
1 990000
3 2756000
9 9269000
Deferred tax liabilities
n/a
1 777000
0 484000
0 203000
0 0
0 0
0 0
0 63000
Other liabilities
n/a
0 380000
1 509000
2 2093000
1 1291000
1 1058000
0 67000
0 63000
Total liabilities
n/a
119 119219000
148 148354000
90 90177000
92 91636000
56 56250000
54 53932000
52 51769000
Commitments and contingencies (Note 13)
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Common stock, $0.01 par value, 75,000,000 shares authorized; 14,107,126 and 9,624,275 shares issued at March 31, 2016 and 2015, respectively
n/a
0 448000
1 507000
1 520000
1 603000
0 79000
0 96000
0 141000
Additional paid-in capital
n/a
698 698417000
886 885704000
897 896603000
924 923847000
967 967100000
986 985921000
1,012 1011813000
Treasury stock, at cost, 51,506 and 34,067 shares at March 31, 2016 and 2015, respectively
n/a
0 0
0 0
0 -271000
0 -313000
0 -370000
-1 -771000
-1 -881000
Accumulated other comprehensive income (loss)
n/a
-7 -7011000
4 3817000
2 2027000
1 1112000
2 1839000
0 -308000
1 660000
Accumulated deficit
n/a
-411 -410889000
-597 -597173000
-734 -734000000
-800 -800131000
-856 -856389000
-905 -905045000
-928 -928184000
Total stockholders' equity
n/a
281 280965000
293 292855000
165 164879000
125 125118000
112 112259000
80 79893000
84 83549000
Total liabilities and stockholders' equity
n/a
400 400184000
441 441209000
255 255056000
217 216754000
169 168509000
134 133825000
135 135318000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Jun 6, 2012 n/a restated on Nov 30, -1 n/a restated on Jun 5, 2014 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (55 items missing)
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net loss
-17
16
-186
-137
-66
-56
-49
-23
Stock-based compensation expense-non-employee
0
0
0
0
0
0
0
0
Write-off of advanced payment to The Switch
0
0
0
21
0
0
0
0
Patent costs
0
0
0
5
0
0
0
0
Restructuring charges, net of payments
0
0
0
3
0
0
0
0
Impairment of goodwill
0
0
49
0
0
0
0
0
Depreciation and amortization
8
10
11
15
13
11
10
8
Stock-based compensation expense
10
14
13
10
8
11
6
3
Impairment of minority interest investments
0
0
1
2
5
1
3
1
Provision for excess and obsolete inventory
0
0
64
4
2
0
1
3
Provision for doubtful accounts receivable
1
-1
0
0
0
0
0
0
Re-valuation of warrant
1
0
0
0
0
0
0
0
Adverse purchase commitment losses (recoveries), net
0
0
39
-1
-8
0
0
0
Write-off prepaid taxes
0
0
6
0
0
1
0
0
Gain on sale from minority interest investments
0
0
0
0
0
0
0
-3
Loss from minority interest investments
0
0
1
2
2
1
1
0
Change in fair value of derivatives and warrants
0
0
0
0
-8
-2
-4
0
Loss on extinguishment of debt
0
0
0
0
0
5
0
0
Reversal of Catlin legal costs
0
0
0
0
0
0
-2
0
Non-cash interest expense
0
0
0
0
12
8
1
0
Deferred income taxes
0
-3
4
0
0
0
0
0
Other non-cash items
1
1
1
1
3
2
-2
1
Accounts receivable
18
-17
63
-5
-1
11
-3
-9
Inventory
-24
-1
-52
-8
-6
13
-2
-1
Prepaid expenses and other current assets
-8
-10
-15
2
9
13
-2
6
Accounts payable and accrued expenses
27
24
0
-64
-22
-11
6
2
Deferred revenue
15
7
-21
9
10
-21
4
7
Net cash used in operating activities
-2
41
-23
-141
-45
-13
-33
-5
Purchase of property, plant and equipment
-7
-17
-41
-11
-1
0
-1
-1
Purchase of marketable securities
-90
-82
-158
0
0
0
0
0
Proceeds from the sale of property, plant and equipment
0
0
0
0
0
0
0
0
Proceeds from the maturity of marketable securities
89
59
105
110
5
0
0
0
Change in restricted cash
6
2
0
-9
4
5
2
3
Purchase of intangible assets
-1
-2
-3
-4
0
0
0
0
Purchase of minority investments
0
-1
-10
-2
0
0
0
0
Advanced payment for planned acquisition
0
0
0
-21
0
0
0
0
Proceeds from sale of minority interests
0
0
0
0
0
0
0
3
Change in other assets
-1
0
1
0
0
0
0
0
Net cash provided by investing activities
-3
-40
-105
63
7
4
2
5
Employee taxes paid related to net settlement of equity awards
0
0
0
0
0
0
0
0
Proceeds from the issuance of debt, net of expenses
0
0
0
5
33
10
1
0
Repayment of debt
0
0
0
-5
-2
-5
-7
-4
Proceeds from public equity offering, net
0
0
155
0
0
7
15
22
Proceeds from exercise of employee stock options and ESPP
12
19
8
0
0
0
0
0
Net cash provided by financing activities
12
19
163
0
31
13
9
18
Effect of exchange rate changes on cash and cash equivalents
-4
-3
1
0
0
0
-1
0
Net increase/(decrease) in cash and cash equivalents
3
17
36
-78
-7
4
-23
19
Non-cash contingent consideration in connection with acquisitions
11
11
10
0
0
0
0
0
Cash and cash equivalents at end of year
71
88
124
46
39
43
20
39
Cash paid for income taxes, net of refunds
5
12
16
13
0
1
0
2
Issuance of common stock to settle liabilities
1
2
1
1
19
24
2
0
Cash paid for interest
0
0
0
0
1
1
1
1
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Jun 14, 2013 n/a
calculated values,
restated on Jun 5, 2014 n/a
calculated values,
restated on May 28, 2015 n/a
calculated values,
restated on May 31, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,